1 |
Ager EI, Neo J, Christophi C (2008). The renin-angiotensin system and malignancy. Carcinogenesis, 29, 1675-84.
DOI
|
2 |
Alves Corre.a SA, Ribeiro de Noronha SM, Nogueira-de-Souza NC, et al (2009). Association between the angiotensinconverting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women. J Renin Angiotensin Aldosterone Syst, 10, 51-8.
DOI
|
3 |
Attia J, Thakkinstian A, D'Este C (2003). Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol, 56, 297-303.
DOI
|
4 |
Gonzalez-Zuloeta LAM, Arias VA, Sayed-Tabatabaei FA, et al (2005). Angiotensin-converting enzyme gene insertion/ deletion polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 2143-6.
DOI
|
5 |
Haiman CA, Henderson SO, Bretsky P, et al (2003). Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res, 63, 6984-7.
|
6 |
Koh WP, Yuan JM, Sun CL, et al (2003). Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res, 63, 5738.
|
7 |
Lever AF, Hole DJ, Gillis CR, et al (1998). Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet, 352, 179-84.
DOI
ScienceOn
|
8 |
Mendizabal-Ruiz AP, Morales JA, Castro Marti Nez X, et al (2011). RAS polymorphisms in cancerous and benign breast tissue. J Renin Angiotensin Aldosterone Syst, 12, 85-92.
DOI
|
9 |
Namazi S, Monabati A, Ardeshir-Rouhani-Fard S (2010). Association of angiotensin I converting enzyme (insertion/ deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors in Iranian population. Mol Carcinog, 49, 1022-30.
DOI
|
10 |
Rigat B, Hubert C, Alhenc-Gelas F, et al (1990). An insertion/ deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest, 86, 1343-6.
DOI
ScienceOn
|
11 |
Rocken C, Lendeckel U, Dierkes J, et al (2005).The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism.Clin Cancer Res, 11, 2526-30.
DOI
ScienceOn
|
12 |
Wacholder S, Hartge P, Prentice R, et al(2010). Performance of common genetic variants in breast-cancer risk models. N Engl J Med, 362, 986-993.
DOI
|
13 |
Sayed-Tabatabaei FA, Schut AF, Hofman A,et al(2004).A study of gene-environment interaction on the gene for angiotensin converting enzyme: a combined functional and population based approach. J Med Genet, 41, 99-103.
DOI
|
14 |
Setiawan VW, Monroe KR, Wilkens LR, et al(2009). Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol, 169, 1251-9.
DOI
|
15 |
Smigal C, Jemal A, Ward E, et al (2006). Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin, 56, 168-83.
DOI
ScienceOn
|
16 |
Van der Knaap R, Siemes C, Coebergh JW, et al (2008). Renin- angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. Cancer, 112, 748-57.
DOI
ScienceOn
|
17 |
Yuan JM, Koh WP, Sun CL, et al (2005). Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis, 26,1389-94.
DOI
|
18 |
Villard E, Tiret L, Visvikis S, et al (1996). Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet, 58, 1268-78.
|
19 |
Wang YJ, Pan Y (2012). Angiotensinogen gene M235T polymorphism and risk of coronary artery disease: A metaanalysis. Mol Med Report, 6, 884-8.
DOI
|
20 |
Yaren A, Turgut S, Kursunluoglu R, et al (2007). Insertion/ deletion polymorphism of the angiotensin I-converting enzyme gene in patients with breast cancer and effects on prognostic factors. J Investig Med, 55, 255-61.
DOI
|